ReviewFrontiers in pediatrics2026
Hemodynamic phenotyping of bronchopulmonary dysplasia: from transitional circulation to precision cardiopulmonary care.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Bronchopulmonary dysplasia (BPD) remains one of the most important complications of extreme prematurity and a leading cause of long-term respiratory, cardiovascular, and neurodevelopmental morbidity. Increasing evidence suggests that BPD should be viewed not only as a parenchymal lung disorder but as a complex cardiopulmonary syndrome involving disrupted vascular development, abnormal transitional circulation, and ventricular dysfunction. This review aimed to summarize current evidence on the hemodynamic mechanisms underlying BPD, emphasizing pulmonary vascular disease (PVD), bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), phenotype-based classification, and implications for precision management. Methods: A narrative review of experimental, translational, and clinical studies was performed, focusing on pulmonary vascular development, transitional hemodynamics, patent ductus arteriosus, ventricular function, targeted neonatal echocardiography, and biomarker-based risk stratification in preterm infants. Evidence regarding phenotypic classification and individualized therapeutic strategies was also examined. Results: Emerging evidence demonstrates that abnormal pulmonary vascular growth begins early, often during the transitional circulatory period, and is aggravated by hyperoxia, mechanical ventilation, inflammation, placental dysfunction, and altered pulmonary blood flow. Prolonged exposure to hemodynamically significant left-to-right shunts, particularly patent ductus arteriosus, may contribute to pulmonary overcirculation, edema, and vascular remodeling. Elevated pulmonary vascular resistance leads to right ventricular pressure overload, while left ventricular diastolic dysfunction and pulmonary venous congestion further worsen pulmonary edema and gas exchange. Early hemodynamic assessment using targeted neonatal echocardiography and biomarkers such as NT-proBNP enables detection of subclinical PVD and ventricular dysfunction during the first days of life. Phenotype-based classification reveals overlapping parenchymal, interstitial, congestive, vascular, and airway components, supporting individualized cardiopulmonary management. Conclusions: BPD is increasingly recognized as a heterogeneous cardiopulmonary syndrome in which disturbed hemodynamics and impaired cardiopulmonary coupling play central roles in disease progression and prognosis. Early hemodynamic phenotyping may improve risk stratification, support precision-guided interventions, and offer new opportunities to prevent PVD, BPD-PH, and long-term cardiopulmonary sequelae in extremely preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.